Javelin Biotech Company
Javelin Biotech is a framework for predictive drug discovery designed to improve drug performance prediction in humans. The company's platform enables biopharmaceutical companies to optimize ADME(T) and PD properties, which improve drug discovery and approval of the same, by bringing human-relevant in-vitro data and computational biology or data analytics to pre-clinical drug discovery teams. This accelerates preclinical drug discovery and development by finding human-relevant targets.
Founded Date:
2018-01-01
Last Funding Date:
2019-01-01
Industry:
Quantum Biology
Headquarters:
Woburn,Massachusetts,United States,North America
Employee Number:
11-50
Funding Status:
private
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Founders:
Emily Geishecker,Kevin O'Handley,Murat Cirit